Dr. Kalyan Banerjee’s Clinic Develops Homeopathy Protocols for Prevention of Covid-19 cases
Dr. Kalyan Banerjee’s Clinic Develops Homeopathy
Protocols for Prevention of Covid-19 cases
Bengaluru / April 9, 2021: Delhi-based Dr. Kalyan Banerjee’s Clinic has developed a world-class homeopathy protocol for prevention of Covid-19, which it has dispensed to 2 lakh people in the last one year, helping protect them from the dreaded pandemic. It is counted among the world’s most popular homeopathic prophylaxis protocols today, and the only one to have been validated in an evidence-based manner.
Dr. Kalyan Banerjee, Founder, Dr. Kalyan Banerjee’s Clinic, New Delhi, said, “The homeopathic prophylaxis protocol was developed by us even before the lockdown started. One of the world’s largest datasets of 15,000 of our own patients from 18 countries was then analysed and a protective effect of the prophylaxis protocol was found. Senior doctors at our Clinic have been involved in the management of severe COVID-19 cases, including multiple organ dysfunction syndrome, and are managing more than 100 Covid patients daily. They have also administered the our protocol to Covid patients from all over the world exclusively or as an add-on.”
He added: “Dr. Kalyan Banerjee’s Clinic homeopathy prophylaxis protocol against Covid-19 has been requested by patients and doctors from several hospitals of the world in advanced stages of the disease. We have developed protocols according to case severity and provided these to various organisations on their request. We, of course, encouraged compliance with all public health advisories at all times, no matter where in the world the patient was located.”
There is an old relationship of Dr. Banerjee’s Clinic with Bengaluru. It has more than 25,000 patients in the city. The Clinic at Delhi processes more than 600 telephone, video or email consultation requests from Bengaluru each month. Between 120-150 patients visit Delhi from Bengaluru every month to seek treatment at Dr. Kalyan Banerjee’s Clinic. Said Dr. Kushal Banerjee from Dr. Kalyan Banerjee Clinic, who visits Bengaluru once a month to see patients: “A lacunae in the homeopathic management of life threatening and complicated cases has been highlighted by patients in Bengaluru. Almost a quarter of the patients we see from the city are seeking treatment for respiratory allergies. Others are suffering from skin allergies, auto-immune disorders, cancers, endocrinological disorders, musculoskeletal disorders or gynaecological disorders.”
In another significant development, Dr. Banerjee’s Clinic has released findings from ongoing retrospective observational studies it has been conducting involving data of thousands of its patients from all over India. These show the benefits of homeopathy interventions in the management of chronic kidney disease / kidney failure and hypothyroidism, two very common diseases which have no resolution in conventional medicine.
Hypothyroidism imposes a heavy disease burden with 11% prevalence in India, higher than in developed nations. Lifelong hormone replacement therapy is the only option for patients. An average of 40 cases of hypothyroidism are treated daily at Dr. Kalyan Banerjee’s Clinic. Measuring the levels of Thyroid-stimulating hormone (TSH) is a simple, objective criteria to assess the efficacy of treatment.
The hypothyroidism study at Dr. Kalyan Banerjee’s Clinic analysed the records of 3,500 patients. Their Serum TSH readings were noted at every subsequent visit. Four visits of each patient were analysed with approximate follow-up period of 4 to 24 months. The study found that by the fourth visit, 35-52% of patients demonstrated a marked improvement in their serum TSH readings.
The data indicates that specific homeopathic medicines given to patients were able to improve the functioning of the thyroid gland, thereby bringing down the thyroid stimulating hormone readings. This has the potential of reducing – or entirely stopping – the dosage of thyroid hormone replacement in patients. This runs contrary to the understanding of the natural history of hypothyroidism, which indicates that the progression of the disease is usually not controlled.
Said Dr. Kushal Banerjee from Dr. Kalyan Banerjee Clinic, “This study shows that at the minimum, a third of all hypothyroid patients stand to benefit from homeopathy treatment protocols developed at our Clinic. No other similar therapeutic intervention is available today. Population studies up to now have indicated that there should be no change in the disease progression of these patients. This reversal of progression should be of immense research interest to the healthcare community and indicates a positive therapeutic effect of the specific homeopathic treatment provided to the patients.”
Added Dr. Kalyan Banerjee, “As shown by the study, at least 35% of patients of hypothyroidism stand to benefit from the specific homeopathic treatment provided at Dr. Kalyan Banerjee’s Clinic. This includes, in almost all the patients who demonstrated improvement, a combination of two homeopathic medicines – Ignatia Amara 200c & Conium Maculatum 3c. This indicates the possible discovery of novel medicinal action of these two medicines for the management of hypothyroidism.”
Doctors of Dr. Banerjee’s Clinic also treat an average of 25 cases of chronic kidney disease (CKD) per day. The CKD study conducted by the Clinic analysed raw data from the records of 520 new. Their Serum Urea and Creatinine readings were noted in every subsequent visit. Three visits of each patient at the Clinic were analyzed, with approximate follow up period of 3 to 6 months. The study found that by the third visit, 50% of patients demonstrated significant improvement in their serum urea and creatinine readings. No currently available treatment can affect such a reduction in these two most clinically important readings. Since these readings are a part of the decision-making process of whether to start dialysis or not, homeopathic treatment may help patients avoid the start of dialysis.
Said Dr. Kushal Banerjee, “At the minimum, 50% of the patients of chronic kidney disease stand to benefit from the specific homeopathic treatment provided at Dr. Kalyan Banerjee’s Clinic. This offers the possibility of avoiding or delaying the onset of dialysis. No other similar therapeutic intervention is available today. Serum creatinine and urea levels along with eGFR are used to stage patients of CKD. Reduction in these levels may mean reduction of stage. This has never been demonstrated before. In almost all patients who have demonstrated improvement, a combination of two homeopathic medicines – Bryonia Alba 30c & Lycopodium 30c – was used. This indicates the possible discovery of novel medicinal action of these two homeopathic medicines for the management of CKD.”
Added Dr. Kalyan Banerjee, “These are early findings, but we encourage all doctors to consider the provision of homeopathic treatment for patients of these conditions. The homeopathic medicines have a proven high safety profile and cause no adverse reactions with any other medicines. They are safe to use. We will be happy to work with specialists in these fields to conduct robust trials and collaborate with research bodies to understand the mechanism of action of these remedies for CKD and hypothyroidism.”
Dr. Kalyan Banerjee's Clinic has over 550,000 registered patients. Its doctors see more than 1,000 patients every day.
About Dr. Kalyan Banerjee’s Clinic
The Clinic was founded in 1977 and now treats several hundred patients every day. The rates of cure achieved here, far surpass conventional homeopathy and the Clinic has built a reputation for effective, evidence-based practices with patients and illnesses that are complicated, difficult and in many cases, life threatening. The experienced and well-trained team of doctors at the Clinic is led by Dr. Kalyan Banerjee, an accomplished physician with four decades of practice. The Clinic has been responsible for several million charitable prescriptions over four decades. In addition, facilitation of research, publication and protocol development, are amongst their various philanthropic activities. The clinic also has branches in Noida and Gurgaon now making it very convenient for patients in surrounding areas of Delhi and the National Capital Region for picking up medicines.
The distinctive USP of the clinic is that all patients are provided prescriptions and names of medicines. While these are available at homeopathic pharmacies, patients prefer to take it from Dr. Kalyan Banerjee’s Clinic and centres because of their faith in the high quality of medicines used. A few proprietary homeopathic preparations and medicines are exclusively only available at the Clinic and centres.
About Dr. Kalyan Banerjee
Dr. Kalyan Banerjee has been associated with several government agencies such as the Central Council for Research in Homoeopathy, Ministry of Health and Family Welfare, formerly a member of their Governing Council, and the Central Council for Research in Homoeopathy (CCRH) of the Ministry of AYUSH, holding a seat in the Homeopathic Pharmacopoeia Committee and the Standing Finance Committee. The Government of India awarded him the fourth highest civilian honour of the Padma Shri in 2009, for his contributions to Medicine.
About Dr. Kushal Banerjee
Dr. Kushal Banerjee received his undergraduate degree from Indraprastha University and completed his MD in Homeopathy from Ludhiana. He went on to read for a Master of Science in Evidence Based Medicine at the University of Oxford. The best available information indicates that he is the only homeopath to have ever been admitted to read at Oxford. He is a member of the British Register of Complementary Medicine, England. He has lead-authored research on homeopathy with collaborators from the University of Oxford and Imperial College, London. This is the only example of such a collaboration between these two institutions on homeopathy. He is the only homeopath to have ever been selected to present a paper at 'Evidence Live' - a prestigious convention organised by the Centre for Evidence Based Medicine, University of Oxford and the British Medical Journal.